A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases
source: pixabay.com

A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases

Vanderbilt University has just announced a new collaborative agreement with Soleno Therapeutics in aim to develop KATP channel activators as a therapeutic for rare diseases. This therapy has already been…

Continue Reading A New Collaboration Will Support Research of Prader-Willi Syndrome and Other Rare Diseases
Technology to Treat Prader-Willi Syndrome Has Been Licensed by Tonix Pharmaceuticals
PhotoLizM / Pixabay

Technology to Treat Prader-Willi Syndrome Has Been Licensed by Tonix Pharmaceuticals

Tonix Pharmaceuticals and Inserm, which is the French National Institute of Health and Medical Research, have entered into a licensing agreement in which Tonix will hold the license to oxytocin-based…

Continue Reading Technology to Treat Prader-Willi Syndrome Has Been Licensed by Tonix Pharmaceuticals

Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It

According to a story from metro.co.uk, celebrity Katie Price, an English television personality, author, singer, and designer is reportedly considering part time residential care for her son Harvey. Harvey has…

Continue Reading Residential Care for Prader-Willi Syndrome? This Celebrity is Considering It
Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial
source: pixabay.com

Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial

Prader-Willi Syndrome (PWS) is caused by deleted genes on chromosome 15. This results in improper signaling of satiety, leading to obesity. Individuals with the condition can suffer from respiratory/cardiac disease, gastric…

Continue Reading Extension Study for Prader-Willi Syndrome Initiated After Completion of Phase 2a Trial
Phase III Prader-Willi Syndrome Clinical Trial to be Expanded to Include Younger Patients
RyanMcGuire / Pixabay

Phase III Prader-Willi Syndrome Clinical Trial to be Expanded to Include Younger Patients

According to a story from BioSpace, the biopharmaceutical company Soleno Therapeutics recently announced that it will be updating the minimum age for participating patients in its Phase III clinical trial…

Continue Reading Phase III Prader-Willi Syndrome Clinical Trial to be Expanded to Include Younger Patients
Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial
mohamed_hassan / Pixabay

Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial

According to a story from GlobeNewswire, the biotech company Saniona has recently announced plans to begin the design and initiation of a Phase 2a clinical trial study of its investigational…

Continue Reading Possible Treatment for Hypothalamic Obesity and Prader-Willi Syndrome Will be Tested in Phase 2 Trial